thomsen-friedenreich antigen has been researched along with Angiogenesis, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, H; Bandyopadhyaya, G; Davila, E; Guha, P; Kaczanowska, S; Kalvakolanu, DV; Kaptan, E; Martin, SS; Thompson, K; Vasta, GR | 1 |
Yu, LG | 1 |
1 review(s) available for thomsen-friedenreich antigen and Angiogenesis, Pathologic
Article | Year |
---|---|
The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.
Topics: Antigens, Tumor-Associated, Carbohydrate; Cell Adhesion; Cell Proliferation; Disease Progression; Endothelium; Humans; Mucin-1; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic | 2007 |
1 other study(ies) available for thomsen-friedenreich antigen and Angiogenesis, Pathologic
Article | Year |
---|---|
Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis.
Topics: Adenocarcinoma; Animals; Antifreeze Proteins; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Apoptosis; Fish Proteins; Gadus morhua; Galectin 3; Human Umbilical Vein Endothelial Cells; Humans; Jurkat Cells; Male; Mice; Neoplasm Metastasis; Neoplasm Proteins; Neovascularization, Pathologic; Prostatic Neoplasms; T-Lymphocytes | 2013 |